November 9, 2022
Marijuana use increased significantly during the pandemic in states where it is illegal and in states where medical marijuana is legal, according to a new study. […]
November 4, 2022
The US Food and Drug Administration (FDA) has expanded the indication for tenofovir alafenamide (Vemlidy) to children aged 12 years and older with chronic hepatitis B […]
October 25, 2022
The US Food and Drug Administration (FDA) has granted accelerated approval to teclistamab (Tecvayli, Janssen Biotech, Inc.) for adults with relapsed or refractory multiple myeloma after […]
October 24, 2022
The US Food and Drug Administration (FDA) has approved a new immunotherapy combination for use in the treatment of unresectable hepatocellular carcinoma (HCC), the most common […]
October 24, 2022
The US Food and Drug Administration (FDA) has approved the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) for adults with nonradiographic axial spondyloarthritis (nr-axSpA) who have objective […]
October 17, 2022
Labeling for a Medtronic pacing lead, already indicated for stimulation of the His bundle, has been expanded to include the left bundle branch (LBB), the company […]
October 17, 2022
The US Food and Drug Administration has granted 510(k) clearance for Abiomed’s Impella Low Profile Sheath used to place and manage Impella heart pumps. “The Low […]
October 12, 2022
The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure (HF) and […]
October 7, 2022
The US Food and Drug Administration (FDA) has approved a whooping cough vaccine that protects newborns under 2 months of age. The federal agency on Friday […]